Cambridge-based Alchemie Technology receives recognition for sustainability in the textile industry
Cambridge: Monday 21st October 2024: Leading clean-tech company Alchemie Technology was featured in a prestigious new book marking the 75th anniversary of the Commonwealth and King Charl
Ellison Institute of Technology Los Angeles Accelerates Cancer Research with Sapio LIMS
Innovative research institute streamlines operations and enhances collaboration with unified laboratory informatics platformBaltimore, MD, 22 October 2024 – Sapio Sciences, the science-aware™ lab informa
New blog: What are the benefits of digital pathology?
Digital pathology is used within pathology, computer science and image analysis and is transforming how pathologists diagnose and research diseases. Within this article, we will conduct a deep dive into the benefits of digital pathology.
Optibrium demonstrates superior molecular docking method for small molecules and macrocycles
Surflex-Dock structure-based design method outperforms other molecular docking methods for predicting non-cognate ligand pose of macrocyclic compounds Results published Open Access in Journal of Computer-Aided Molecular Design
Cognidox unveils exciting new integration features in v10.4 release
Cognidox, a leading provider of document management solutions for the high-tech, medical device, and life sciences industries, has unveiled the latest innovations in their v10.4 platform release.
Award highlights from Costello Medical Consulting
Award winning commitment.
The impact of AI on the event production industry: jobs created and lost
Every event we’ve worked on in the last 12 months has in some way mentioned AI (except Munich Beer Festival and Top Clown UK).
The first five: Marshall USA selects crew chiefs for Greensboro facility
Marshall’s new facility in Greensboro, North Carolina, has taken a major step forward with the recruitment of a first team of five highly qualified maintenance crew chiefs.
Overcoming pharmaceutical and other materials issues before they exist
Two new scientific papers on the conclusions of the 7th Crystal Structure Prediction Blind Test.
Lily Lin visits Gluetacs Therapeutics
On 15th October 2024, Lily Lin, CEO of Excellence First Enterprise Consultancy, accompanied by Iris Li and Yang Qing from the Lingang Cambridge Network (LCN), visited Gluetacs Therapeutics, a pioneering biotech company and LCN member. Dr. Yang, the founder of Gluetacs, along with his colleagues, warmly welcomed Lily and provided updates on their recent North American business expansion.
Connect and collaborate at a free business workspace in South Cambridgeshire
Regional businesses, entrepreneurs, community groups and charities are being invited to Cambourne to try a new collaborative working space - free of charge until the new year!
Cambridge and GSK announce new five-year collaboration aiming for improved outcomes for patients with hard-to-treat kidney and respiratory diseases
The ambition of the partnership is to treat immune-related diseases more precisely with existing therapies and to rapidly develop new ones.
The economic cost of living with a rare disease across Europe
Although rare diseases affect a relatively small number of patients, collectively there are an estimated 30 million people in Europe living with 6,000-7,000 known rare diseases (RDs).
Price achieved for first indication vs. ASMR
CRA Life Sciences continues its series on leveraging RADAR, its orphan drug data repository, with a focus on PMA trends between ASMR outcomes and average annual treatment costs. The analysis shows a clear correlation between the ASMR rating and the level of price achieved.
Costello Medical Consulting gains B Corp Certification
Leading the way in reinventing business by pursuing purpose as well as profit.
Axol Bioscience acquires Phenocell to advance human disease models
Acquisition expands Axol’s iPSC-derived cell models and service offering to include ophthalmology and dermatologyCAMBRIDGE / EDINBURGH, UK, and GRASSE, FRANCE, 21 October 2024: Axol Bioscience Ltd.
It Takes a City's latest newsletter - now available
Our latest newsletter has been published.
How continuous improvement strategies drive business growth
Our article on Continuous Improvement (CI) as a growth strategy highlights how businesses can adopt the ‘Kaizen’ philosophy to drive long-term success through incremental digital marketing improvements. CI revolves around iterative analysis and adjustments across SEO, PPC, content strategy, and user experience to ensure consistent performance gains. By fostering collaborative, data-driven…
Prism support investment group through 10th acquisition
Prism Corporate Broking are pleased to announce that we have supported rapidly growing investment company, Milbank Group, on its acquisition of Scottish full-service liquid products manufacturer, Superfine Manufacturing Ltd. This is the 10th acquisition we have facilitated for the Group.
Personal growth & authentic leadership
At the start of the month our MD, Nick O'Sullivan was invited to speak to the final year students at Nottingham Trent University's Fashion Management course on all things leadership and management and how to find their own authentic style.
eg technology launch Technology Readiness Level (TRL) assessment
Comprised of both a self-assessment diagnostic tool, through which innovators can assess the Technology Readiness Level of each integral element of their development
The power of pauses in public speaking
When putting together a presentation, it pays to not just work on the words - but also, to think carefully about how you're going to use those words...
Key challenges in the medical device startup landscape
Co-authored by Samantha Shelley, SQMS.
New lab to open to make cutting-edge CAR-T cells in Cambridge
A new state-of-the-art laboratory is set to open at Addenbrooke’s Hospital that will deliver ‘home-grown’ CAR-T cells to help improve treatment for blood cancers.
Council takes action to reduce its carbon emissions by another 10%
CAMBRIDGE City Council has achieved a reduction of 10.8% in the council’s own emissions since 2022/23 – a reduction of approximately 500 tonnes of CO2 compared to the previous year. This was highlighted in the Annual Climate Change Strategy and Carbon Management Plan report which notes the actions taken to achieve these reductions.